沟通痴呆风险:一个范围审查
Maja Swirska1, Axel A S Laurell1,2, Emad Sidhom1,2
1Department of Psychiatry, Cambridge University, Cambridge, UK.
BMJ neurology open
|July 30, 2025
概括
沟通痴呆风险至关重要,因为新的测试出现了. 虽然患者希望有风险信息用于规划,但高风险人群可能会经历痛苦,并高估自己患痴呆症的可能性.
科学领域:
- 神经科学是一个神经科学.
- 医学沟通 医学沟通
- 生物标志物研究 生物标志物研究
背景情况:
- 痴呆症涉及由于神经退行性疾病而导致的渐进性认知和功能衰退.
- 基因检测,成像和液体生物标志物的进步增加了痴呆症风险评估的频率和复杂性.
- 有效沟通痴呆风险正在成为患者护理的关键方面.
研究的目的:
- 系统地检索有关痴呆风险沟通的文献.
- 确定风险沟通的组成部分,影响因素和现有的临床指南.
- 了解患者,家庭,护理人员和医疗保健专业人员的观点.
主要方法:
- 对115篇文章进行系统范围审查.
- 分析包括对遗传,粉样蛋白和其他生物标志物的研究.
- 包括风险个人,家庭,照顾者和医疗保健专业人员的观点.
主要成果:
- 患者希望获得痴呆风险信息,以便在未来规划和参与研究.
- 风险披露没有显著影响焦虑或抑郁,但在高风险人群中增加了痛苦.
- 高风险人群往往高估了他们的痴呆症可能性;有效的沟通工具强调教育,清晰度和后续.
- 在血液生物标志物,非阿尔茨海默氏症痴呆症和与受损个人沟通方面存在文学差距.
结论:
- 风险沟通对于医疗保健专业人员来说至关重要,特别是在新兴的痴呆症预测技术方面.
- 明确的沟通,患者教育和定期跟进是有效风险披露的关键组成部分.
- 对不同类型的痴呆和不同患者群体的特定生物标志物和沟通策略需要进一步的研究.
更多相关视频
07:31Implementation of a Real-Time Psychosis Risk Detection and Alerting System Based on Electronic Health Records using CogStack
Published on: May 15, 2020
7.2K
06:23The 4 Mountains Test: A Short Test of Spatial Memory with High Sensitivity for the Diagnosis of Pre-dementia Alzheimer's Disease
Published on: October 13, 2016
32.7K
相关概念视频
01:30Dementia
166
Dementia is a collective term for cognitive disorders primarily affecting memory, thinking, and reasoning. It is not a specific disease but a syndrome, with Alzheimer's disease being the most common cause, accounting for approximately 60-80% of cases. Other types include vascular dementia, Lewy body dementia, and frontotemporal dementia. Dementia affects millions worldwide, particularly older adults, though it is not a normal part of aging.
The progression of dementia is generally gradual....
The progression of dementia is generally gradual....
166
01:26Alzheimer's Disease: Overview
669
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
669
01:23Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
176
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
176
01:22Alzheimer's Disease: Treatment
262
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
262
01:29Documentation in Long-Term and Home Healthcare Setting
988
Documentation in long-term care facilities and home healthcare settings is crucial for ensuring continuous, coordinated, and comprehensive care for patients. Each setting has its specific documentation processes and tools:
Long-Term Care Facilities
Long-Term Care Facilities
988
01:21Barriers to Effective Communication II
3.8K
The barriers to effective communication also include cultural barriers, semantic barriers, gender barriers, and time constraints.
Cultural barriers:
Differences in values, beliefs, religion, knowledge, and tradition can significantly impact communication. Awareness of nonverbal cues is critical, especially when conversing with a patient from a different culture. What appears appropriate in one culture may be inappropriate in another.
Semantic barriers:
As a result of their tendency to use...
Cultural barriers:
Differences in values, beliefs, religion, knowledge, and tradition can significantly impact communication. Awareness of nonverbal cues is critical, especially when conversing with a patient from a different culture. What appears appropriate in one culture may be inappropriate in another.
Semantic barriers:
As a result of their tendency to use...
3.8K